Trial Profile
Double Blind, Placebo Controlled Dose Ranging Study for the Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of GLPG0492 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs DT 200 (Primary)
- Indications Cachexia; Duchenne muscular dystrophy
- Focus Adverse reactions
- Sponsors Galapagos NV
- 27 May 2014 New trial record